Fractional CO2 Laser in the Treatment for Cesarian Scar

Fractional CO2 laser can improve the Cesarian scar

Study Overview

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 116
        • Wan Fang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female receiving Cesarean surgery for more than 1 month

Exclusion Criteria:

  • Pregnancy
  • Keloid
  • Photosensitivity
  • Wound
  • Pacemaker
  • Recent retinoid intake

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Pulsed dye laser (V-beam)
Pulsed dye laser: 5mm,1.5ms,8J,delay cooling device 30/30,one pass
Experimental: Experimental group
Fractional CO2 laser(eCO2)and pulsed dye laser (V-beam)
Fractional CO2 laser: 50 mJ, 100 spots/cm2, a scan area of 4_4mm, static mode, and two passes Pulsed dye laser: 5mm,1.5ms,8J,delay cooling device 30/30,one pass

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of Vancouver Scar Scale (VSS)
Time Frame: 1st, 5th, 7th month
We measured quartile grading scale at 1st, 5th and 7th months of study and evaluated the change of the scale
1st, 5th, 7th month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quartile grading scale
Time Frame: 5th, 7th month
We measured quartile grading scale at 5th and 7th months of study.
5th, 7th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

July 24, 2012

First Submitted That Met QC Criteria

July 27, 2012

First Posted (Estimate)

July 31, 2012

Study Record Updates

Last Update Posted (Estimate)

July 13, 2016

Last Update Submitted That Met QC Criteria

July 12, 2016

Last Verified

July 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • TMU-JIRB 201203007

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarian Scar

Clinical Trials on Pulsed dye laser

Subscribe